Body Weight Loss After Myocardial Infarction in Rats as a Marker of Early Heart Failure Development

Archives of Medical Research

Volumn 42, Issue 4, 2011, Pages 274-280

  Faria, Thaís de Oliveira ^a   Baldo, Marcelo Perim ^a   Simões, Maylla Ronacher ^a   Pereira, Raquel Binda ^a   Mill, José Geraldo ^a   Vassallo, Dalton Valentim ^a,b   Stefanon, Ivanita ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b EMESCAM   (Brazil)

Author keywords

Body weight; Cachexia; Heart failure; Infarct area; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLUID INTAKE; FOOD INTAKE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; MORPHOMETRICS; NONHUMAN; RAT; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; ROC CURVE; VENTRICULAR FUNCTION, LEFT; WEIGHT LOSS;

EID: 79961076110     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.06.002     Document Type: Article

References (44)

1. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10:933-989.
2. Anker S.D., Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002, 85:51-66.
3. Lopez-Jimenez F., Wu C.O., Tian X., et al. Weight change after myocardial infarction-the enhancing recovery in coronary heart disease patients (ENRICHD) experience. Am Heart J 2008, 155:478-484.
4. Pocock S.J., McMurray J.J.V., Dobson J., et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 2008, 29:2641-2650.
5. Kennedy L.M.A., Dickstein K., Anker S.D., et al. Weight-change as a prognostic marker in 12,550 patients following acute myocardial infarction or with stable coronary artery disease. Eur Heart J 2006, 27:2755-2762.
6. Nagaya N., Uematsu M., Kojima M., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001, 104:1430-1435.
7. Héliès-Toussaint C., Moinard C., Rasmusen C., et al. Aortic banding in rats as a model to investigate malnutrition associated with heart failure. Am J Physiol Regul Integr Comp Physiol 2005, 288:1325-1331.
8. Akashi Y.J., Palus S., Datta R., et al. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int J Cardiol 2009, 137:267-275.
9. Palus S., Akashi Y., von Haehling S., et al. The influence of age and sex on disease development in a novel animal model of cardiac cachexia. Int J Cardiol 2009, 133:388-393.
10. Baldo M.P., Davel A.P.C., Nicoletti-Carvalho J.E., et al. Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats. J Cardiovasc Pharmacol 2008, 52:375-380.
11. Sartório C.L., Pinto V.D., Cutini G.J.S., et al. Effects of inducible nitric oxide synthase inhibition on the rat tail vascular bed reactivity three days after myocardium infarction. J Cardiovasc Pharmacol 2005, 45:321-326.
12. Mill J.G., Stefanon I., Leite C.M., et al. Changes in performance of surviving myocardium after left ventricular infarction in rats. Cardiovasc Res 1990, 24:748-753.
13. Pinto J.M., Boyden P.A. Electrical remodeling in ischemia and infarction. Cardiovasc Res 1999, 42:284-297.
14. Deten A., Volz H.C., Briest W., et al. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 2002, 55:329-340.
15. Yang F., Liu Y.H., Yang X.P., et al. Myocardial infarction and cardiac remodeling in mice. Exp Physiol 2002, 87:547-555.
16. Gajarsa J.J., Kloner R.A. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 2011, 16:13-21.
17. Joseph S.M., Cedars A.M., Ewald G.A., et al. Acute decompensated heart failure. Contemporary medical management. Tex Heart Inst J 2009, 36:510-520.
18. Summers R.L., Amsterdam E. Pathophysiology of acute decompensated heart failure. Heart Fail Clin 2009, 5:9-17.
19. Pereira R.B., Sartório C.L., Vassallo D.V., et al. Differences in tail vascular bed reactivity in rats with and without heart failure following myocardial infarction. J Pharmacol Exp Ther 2005, 312:1321-1325.
20. Park M., Shen Y.T., Gaussin V., et al. Apoptosis predominates in nonmyocytes in heart failure. Am J Physiol Heart Circ Physiol 2009, 297:785-791.
21. Maurice J.P., Shah A.S., Kypson A.P., et al. Molecular β-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol Heart Circ Physiol 1999, 276:1853-1860.
22. Triposkiadis F., Karayannis G., Giamouzis G., et al. The sympathetic nervous system in heart failure. Physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009, 54:1747-1762.
23. Makino T., Hattori Y., Matsuda N., et al. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on β-adrenoceptor signaling in heart failure produced by myocardial infarction in rabbits: reversal of altered expression of β-adrenoceptor kinase and Giα. J Pharmacol Exp Ther 2003, 304:370-379.
24. Brum P.C., Rolim N.P.L., Bacurau A.V.N., et al. Neurohumoral activation in heart failure: the role of adrenergic receptors. An Acad Bras Cienc 2006, 78:485-503.
25. Prunier F., Gaertner R., Louedec L., et al. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol 2002, 283:346-352.
26. Yu Y., Zhang Z.H., Wei S.G., et al. Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction. Circ Res 2007, 101:304-312.
27. Scarlett J.M., Bowe D.D., Zhu X., et al. Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure. J Endocrinol 2010, 206:121-130.
28. Francis J., Weiss R.M., Wei S.G., et al. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regulatory Integrative Comp Physiol 2001, 281:1734-1745.
29. Ling P.R., Schwartz J.H., Bistrian B.R. Mechanisms of host wasting induced by administration of cytokines in rats. Am J Physiol Endocrinol Metab 1997, 35:333-339.
30. Raina N., Jeejeebhoy K.N. Changes in body composition and dietary intake induced by tumor necrosis factor α and corticosterone-individually and in combination. Am J Clin Nutr 1998, 68:11284-11290.
31. Steffen B.T., Lees S.J., Booth F.W. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. J Appl Physiol 2008, 105:1950-1958.
32. Sun M., Dawood F., Wen W.H., et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004, 110:3221-3228.
33. Hedayat M., Mahmoudi M.J., Rose N.R., et al. Proinflammatory cytokines in heart failure: double-edged sword. Heart Fail Rev 2010, 15:543-562.
34. Moro C., Jouan M.G., Rakotovao A., et al. Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling. Am J Physiol Heart Circ Physiol 2007, 293:3014-3019.
35. Sun Y. Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction. J Mol Cell Cardiol 2010, 48:483-489.
36. Brink M., Wellen J., Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest 1996, 97:2509-2516.
37. Brink M., Price S.R., Chrast J., et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 2001, 142:1489-1496.
38. Bianchi P.R., Gumz B.P., Giuberti K., et al. Myocardial infarction increases reactivity to phenylephrine in isolated aortic rings of ovariectomized rats. Life Sci 2006, 78:875-881.
39. Sobel B.E., Bresnahan G.F., Shell W.E., et al. Estimation of infarct size in man and its relation to prognosis. Circulation 1972, 46:640-648.
40. Geltman E.M. Infarct size as a determinant of acute and long-term prognosis. Cardiol Clin 1984, 2:95-103.
41. Burns R.J., Gibbons R.J., Yi Q., et al. The relationships of the left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002, 39:30-36.
42. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979, 44:503-512.
43. Saraiva R.M., Kanashiro-Takeuchi R.M., Antonio E.L., et al. Rats with high left ventricular end-diastolic pressure can be identified by Doppler echocardiography one week after myocardial infarction. Braz J Med Biol Res 2007, 40:1557-1565.
44. Santos A.A., Helber I., Flumignan R.L.G., et al. Doppler echocardiographic predictors of mortality in female rats after myocardial infarction. J Card Fail 2009, 15:163-168.